Risk-benefit analysis of nucleic acid testing: the French experience.
Saura
C
C
Agence Française du Sang, France.
Couroucé
A M
AM
Pillonel
J
J
Costagliola
D
D
Flan
B
B
Defer
C
C
Coste
J
J
Rouzioux
C
C
D001782:Blood Donors; D001803:Blood Transfusion; D003362:Cost-Benefit Analysis; D005602:France; D006678:HIV / Q000302:isolation & purification; D016174:Hepacivirus / Q000302:isolation & purification*; D006515:Hepatitis B virus / Q000302:isolation & purification; D006801:Humans; D010949:Plasma / Q000821:virology; D012367:RNA, Viral / Q000097:blood*; D012307:Risk Factors; D065227:Transfusion Reaction
D012367:RNA, Viral